Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asahi Ito

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Cancer Medicine|April 27, 2023
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasiaTomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Blood Advances|October 22, 2020
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational studyKentaro Yonekura, Shigeru Kusumoto, Ilseung Choi, et al.
International Journal of Hematology|February 15, 2023
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphomaTomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Haematologica|April 14, 2022
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphomaNorio Tanaka, Seiichi Mori, Kazuma Kiyotani, et al.
Leukemia Research|November 12, 2013
Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myelomaAtsushi Inagaki, Emi Tajima, Miyuki Uranishi, et al.
British Journal of Haematology|October 11, 2021
Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumabKisato Nosaka, Shigeru Kusumoto, Nobuaki Nakano, et al.
Blood|May 5, 2023
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axisKazuaki Kameda, Ryo Yanagiya, Yuji Miyatake, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Cancer Medicine|April 27, 2023
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasiaTomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Blood Advances|October 22, 2020
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational studyKentaro Yonekura, Shigeru Kusumoto, Ilseung Choi, et al.
International Journal of Hematology|February 15, 2023
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphomaTomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Haematologica|April 14, 2022
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphomaNorio Tanaka, Seiichi Mori, Kazuma Kiyotani, et al.
Leukemia Research|November 12, 2013
Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myelomaAtsushi Inagaki, Emi Tajima, Miyuki Uranishi, et al.
British Journal of Haematology|October 11, 2021
Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumabKisato Nosaka, Shigeru Kusumoto, Nobuaki Nakano, et al.
Blood|May 5, 2023
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axisKazuaki Kameda, Ryo Yanagiya, Yuji Miyatake, et al.
Pageof 7